← Back to Bills
HR 3382118th CongressFailed / ExpiredHouse

Colorectal Cancer Payment Fairness Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 5, 2025
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Colorectal Cancer Payment Fairness Act (H.R. 3382) is a health policy bill introduced in the 118th Congress aimed at addressing payment issues related to colorectal cancer care. The bill was referred to the Subcommittee on Health but did not advance further and ultimately failed or expired. Specific details about the bill's provisions, including payment reforms or mechanisms, are not available in the provided source data.

Bottom Line

H.R. 3382 sought to reform payment structures for colorectal cancer treatment but did not progress beyond subcommittee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill focuses on payment fairness in colorectal cancer care within the health policy area.
  • It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
  • No official summary or full text is available, limiting detailed analysis of its provisions.
Who Benefits?

['Patients undergoing colorectal cancer treatment who may experience changes in payment policies', 'Healthcare providers and facilities involved in colorectal cancer care', 'Health insurers and payers potentially affected by payment reforms']

Potential Concerns

['Lack of available full text and summary limits understanding of implementation challenges and cost implications', 'Unclear authority and oversight mechanisms due to missing detailed provisions', 'Potential tradeoffs between payment fairness and healthcare cost containment cannot be assessed']

Political Context

The bill was introduced in the House of Representatives during the 118th Congress and referred to the Subcommittee on Health. It did not advance further and expired, indicating limited legislative momentum or prioritization within the congressional session. The absence of detailed legislative text or summary suggests it did not receive extensive public or legislative scrutiny.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['Potential changes in payment fairness could influence colorectal cancer treatment accessibility and provider reimbursement patterns if implemented.', 'Payment reforms might affect insurance coverage policies and healthcare cost structures related to colorectal cancer care.']

GovScope Watchdog Notes

The absence of an official summary and full bill text significantly limits the ability to conduct a thorough transparency and oversight analysis. Tracking such bills requires access to complete legislative documents to evaluate policy impacts, costs, and enforcement mechanisms. The bill's failure to advance past subcommittee referral further restricts available information on legislative intent and stakeholder engagement.

Passage Likelihood: LowConfidence: 70%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready